View Pages
Pfizer raises full-year outlook; Apple misses key metrics with weaker China revenue; Palantir warns of slowing sales growth. Market winners and losers explained.
Editorial companion
Bloomberg highlights three clear market moves: Pfizer moved higher after raising its full-year outlook as newer medicines offset falling Covid sales; Apple fell after quarterly results missed expectations, with China revenue and services margins cited as weaknesses; Palantir slid after guiding to slower sales growth and forecasting about $2.65B in revenue for the next quarter. The clip matters because each reaction tracks to a straightforward corporate surprise, better guidance, disappointing metrics, and weaker guidance, rather than a broader market swing.
View Pages
View Pages
View Pages